Incidence of High Risk and Malignant Pathological Findings in Transgender and Gender Diverse Individuals Undergoing Gender-Affirming Mastectomy.
Rachel L McCaffreyAndrew J JamesRicardo A Torres-GuzmanJamin K AddaeLauren E SullivanElianna DashHanna SlutskyZoe R FinerPatrick E AssiSalam Al-KassisPublished in: Annals of surgical oncology (2024)
The present study found that patients undergoing GAHT should not be screened for breast cancer with increased frequency compared with cis-gender women. Additionally, it may be appropriate for trans women under the age of 25 with normal breast cancer risk to forego pathological breast tissue examination.